Overnight Digest: Stocks to watch out on May 28
Overnight Digest: Stocks to watch out on May 28

Overnight Digest: Stocks to watch out on May 28

Shohini Nath Article rating: 5.0

The stocks that are likely to witness significant movement on the bourses on May 28 are Colgate Palmolive, Brigade Enterprises, NIIT Technologies, Sterlite Technologies and Ratnamani Metals & Tubes.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 5.0

The markets on May 27, 2019 opened up. BSE Sensex is trading at 39,670.59, up by 235.87 points and the Nifty is trading at 11,924.60, up by 80.50 points. 

Should you buy guaranteed monthly income plan from insurers?
Should you buy guaranteed monthly income plan from insurers?

Should you buy guaranteed monthly income plan from insurers?

Henil Shah Article rating: 3.0

Insurance is a product which helps in covering your risk in life. However, there are plans which provide you with guaranteed monthly income. So, should you go for such plans? Let’s find out.

Granules India up 2 per cent on USFDA approval
Granules India up 2 per cent on USFDA approval

Granules India up 2 per cent on USFDA approval

Nidhi Jani Article rating: 3.6

Methylphenidate hydrochloride extended-release capsules are used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The company has submitted a total 19 ANDAs out of which 16 are waiting for approval.

Glenmark gains on receiving USFDA for Aspirin capsules
Glenmark gains on receiving USFDA for Aspirin capsules

Glenmark gains on receiving USFDA for Aspirin capsules

Shohini Nath Article rating: 2.5

Shares of Glenmark were trading in green in early trade session as Glenmark Pharmaceuticals’ subsidiary, Glenmark Pharmaceuticals Inc, USA has been granted final approval by the USFDA for Aspirin and Extended‐Release Dipyridamole Capsules.


RSS
First30793080308130823084308630873088Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR